Literature DB >> 3896176

An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. European Working Party on High Blood Pressure in the Elderly (EWPHE).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3896176

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  9 in total

Review 1.  Clinical trials and clinical practice in the elderly. A focus on hypertension.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 2.  Pharmacotherapy for hypertension in adults aged 18 to 59 years.

Authors:  Vijaya M Musini; Francois Gueyffier; Lorri Puil; Douglas M Salzwedel; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2017-08-16

Review 3.  Review of the major hypertension trials in the elderly.

Authors:  J Staessen; R Fagard; P Lijnen; R Van Hoof; A Amery
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

Review 4.  Pharmacotherapy for hypertension-induced left ventricular hypertrophy.

Authors:  Leire Leache; Marta Gutiérrez-Valencia; Rosa M Finizola; Elizabeth Infante; Bartolome Finizola; Jordi Pardo Pardo; Yris Flores; Ricardo Granero; Kaduo J Arai
Journal:  Cochrane Database Syst Rev       Date:  2021-10-10

5.  Pharmacotherapy for hypertension in adults 60 years or older.

Authors:  Vijaya M Musini; Aaron M Tejani; Ken Bassett; Lorri Puil; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

Review 6.  First-line drugs for hypertension.

Authors:  James M Wright; Vijaya M Musini; Rupam Gill
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

7.  Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.

Authors:  Fiona Campbell; Heather O Dickinson; Julia V F Cook; Fiona R Beyer; Martin Eccles; James M Mason
Journal:  BMC Health Serv Res       Date:  2006-04-05       Impact factor: 2.655

8.  Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.

Authors:  Emma Copland; Dexter Canoy; Milad Nazarzadeh; Zeinab Bidel; Rema Ramakrishnan; Mark Woodward; John Chalmers; Koon K Teo; Carl J Pepine; Barry R Davis; Sverre Kjeldsen; Johan Sundström; Kazem Rahimi
Journal:  Lancet Oncol       Date:  2021-04       Impact factor: 41.316

9.  Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials.

Authors:  Ji-Guang Wang; Jan A Staessen
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.